Procedure for Identification and Characterization of Drugs Efficient Against Mammalian Prion: From a Yeast-Based Antiprion Drug Screening Assay to In Vivo Mouse Models

Publisher： Bentham Science Publishers

E-ISSN： 2212-3989|9|1|31-39

ISSN： 1871-5265

Source： Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol.9, Iss.1, 2009-02, pp. : 31-39

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Zebrafish for drug toxicity screening: bridging the in vitro cell-based models and in vivo mammalian models

By Sukardi Hendrian   Chng Hui Ting   Chan Eric Chun Yong   Gong Zhiyuan   Lam Siew Hong  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 5, 2011-05 ,pp. : 579-589

Informa Healthcare

Access to resources Recommend Favorite

A new structural class of proteasome inhibitors identified by microbial screening using yeast-based assay

By Asai A.   Tsujita T.   Sharma S.V.   Yamashita Y.   Akinaga S.   Funakoshi M.   Kobayashi H.   Mizukami T.  

Biochemical Pharmacology, Vol. 67, Iss. 2, 2004-01 ,pp. : 227-234

Elsevier

Access to resources Recommend Favorite

Strain Specificity and Drug Resistance in Anti-Prion Therapy

By  

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 19, 2013-10 ,pp. : 2397-2406

Bentham Science Publishers

Access to resources Recommend Favorite

Identification of Sanguinarine as a Novel HIV Protease Inhibitor from High-Throughput Screening of 2,000 Drugs and Natural Products with a Cell-Based Assay

By  

Letters in Drug Design & Discovery, Vol. 2, Iss. 5, 2005-08 ,pp. : 364-371

Bentham Science Publishers

Access to resources Recommend Favorite

Increasing the Odds of Drug Hit Identification by Screening Against Receptor Homologs?

By  

Letters in Drug Design & Discovery, Vol. 3, Iss. 3, 2006-04 ,pp. : 200-204

Bentham Science Publishers

Access to resources Recommend Favorite